Streamline Health Solutions (NASDAQ:STRM) Coverage Initiated by Analysts at StockNews.com

StockNews.com began coverage on shares of Streamline Health Solutions (NASDAQ:STRM) in a report published on Saturday morning. The brokerage issued a sell rating on the stock.

Separately, Craig Hallum raised Streamline Health Solutions to a “strong-buy” rating in a report on Thursday, September 5th.

Streamline Health Solutions Price Performance

NASDAQ:STRM opened at $3.68 on Friday. The company has a market cap of $15.72 million, a P/E ratio of -0.74 and a beta of 1.67. The firm’s fifty day moving average price is $2.87 and its two-hundred day moving average price is $5.01. Streamline Health Solutions has a one year low of $1.85 and a one year high of $9.75. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.61 and a quick ratio of 0.61.

Streamline Health Solutions (NASDAQ:STRM) last announced its quarterly earnings results on Monday, December 16th. The company reported ($0.61) EPS for the quarter. Streamline Health Solutions had a negative net margin of 92.72% and a negative return on equity of 44.85%.

About Streamline Health Solutions

Streamline Health Solutions, Inc offers health information technology solutions and associated services for hospitals and health systems in the United States and Canada. The company offers RevID, an automated revenue reconciliation software; eValuator, a coding analysis platform; data comparison engine; coding and clinical documentation improvement (CDI) solutions, including CDI, abstracting, and physician query; and financial management solutions, such as accounts receivable management, denials management, claims processing, spend management, and audit management.